Drug Shortage Report for DEXAMETHASONE
| Report ID | 251206 |
| Drug Identification Number | 02023865 |
| Brand name | DEXAMETHASONE |
| Common or Proper name | DEXAMETHASONE |
| Company Name | PHARMA STULLN INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE SODIUM PHOSPHATE |
| Strength(s) | 0.1% |
| Dosage form(s) | SOLUTION SOLUTION |
| Route of administration | OTIC OPHTHALMIC OTIC OPHTHALMIC |
| Packaging size | 5ml |
| ATC code | S03BA |
| ATC description | CORTICOSTEROIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2025-02-25 |
| Actual start date | 2025-02-25 |
| Estimated end date | |
| Actual end date | 2025-04-07 |
| Shortage status | Resolved |
| Updated date | 2025-04-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6500 TRANS CANADA HIGHWAY, SUITE 400 POINTE-CLAIRE, QUEBEC CANADA H9R 0A5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-04-08 | English | Compare |
| v5 | 2025-04-02 | French | Compare |
| v4 | 2025-04-02 | English | Compare |
| v3 | 2025-02-26 | English | Compare |
| v2 | 2025-02-25 | French | Compare |
| v1 | 2025-02-25 | English | Compare |
Showing 1 to 6 of 6